Financials data is unavailable for this security.
View more
Year on year Moderna Inc 's revenues fell -64.45% from 19.26bn to 6.85bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 8.36bn to a loss of 4.71bn.
Gross margin | 78.43% |
---|---|
Net profit margin | -43.77% |
Operating margin | -53.00% |
Return on assets | -12.62% |
---|---|
Return on equity | -17.52% |
Return on investment | -15.52% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Moderna Inc fell by 289.00m. However, Cash Flow from Investing totalled 4.21bn, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 3.12bn for operations while cash used for financing totalled 1.38bn.
Cash flow per share | -4.89 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 30.98 |
---|---|
Tangible book value per share | 30.74 |
More ▼
Balance sheet in USDView more
Current ratio | 4.39 |
---|---|
Quick ratio | 4.20 |
Total debt/total equity | 0.0549 |
---|---|
Total debt/total capital | 0.0521 |
More ▼